AMGN - Latest News

Amgen Inc. (AMGN), operates in Healthcare / Drug Manufacturers - General, trades on NASDAQ.

Market capitalization stands near $193.39B. Trailing twelve-month P/E ratio is 24.81. Beta to the broader market is 0.42.

The article list below shows the most recent AMGN headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent AMGN Headlines

Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know

zacks.com - Jun 30, 2026

Amgen (AMGN) has been one of the stocks most watched by Zacks. com users lately.

Alphabet Just Joined the Dow Jones Industrial Average. 3 Dow Dividend Stocks to Buy Now.

fool.com - Jun 30, 2026

Cisco Systems is on a roll with its AI-powered platform. Coca-Cola saw volume growth in each of its marketing segments in the first quarter.

Medical journal retracts paper on Amgen's Tavneos drug trial after FDA findings

reuters.com - Jun 29, 2026

The New England Journal of Medicine on Monday retracted an article on a pivotal clinical trial that supported approval of Amgen's ​rare-disease drug,

Viridian Secures First FDA Approval, Sets Up Challenge To Amgen's Tepezza For Thyroid Eye Disease

benzinga.com - Jun 29, 2026

The U. S.

European Regulator Calls for Amgen's Tavneos to Have Authorization Revoked

wsj.com - Jun 26, 2026

The committee is recommending that no new patients start treatment with Tavneos and that existing patients be switched to suitable alternatives.

How News Affects AMGN Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track AMGN's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.

Frequently asked AMGN news questions

What is the latest AMGN news headline?

The most recent AMGN headline (Jun 30, 2026) is "Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.

How fresh is the AMGN news on this page?

News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.

What AMGN news moves options pricing?

Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.

How can I track unusual AMGN options activity related to news?

Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.